Malignant Fibrous Histiocytoma (MFH)
Malignant Fibrous Histiocytoma (MFH), now known as Undifferentiated Pleomorphic Sarcoma (UPS), is an aggressive tumor that typically arises in the deep soft tissues such as muscles or connective tissues.
Causes and Risk Factors
The exact cause of MFH is unclear, but it is believed to develop from mesenchymal cells in the body. Risk factors may include previous radiation therapy, certain genetic conditions, and older age.
Symptoms
Symptoms of MFH can vary depending on its location but may include a painless lump or swelling, pain or tenderness, and restricted movement of nearby joints or muscles.
Diagnosis
Diagnosis typically involves imaging tests such as MRI or CT scans to locate the tumor and a biopsy to confirm the presence of cancerous cells and determine the tumor's type and grade.
Treatment
Treatment for MFH often includes surgical removal of the tumor, followed by radiation therapy to destroy any remaining cancer cells. Chemotherapy may also be used in some cases to reduce the risk of recurrence.
Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. The accuracy of the information presented here is not guaranteed and it should not be relied upon as a substitute for professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any questions you may have about your medical condition or treatment options.